Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of NK Cell Therapy market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of NK Cell Therapymarket, defines the market attractiveness level of NK Cell Therapy market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of NK Cell Therapy industry, describes the types of NK Cell Therapy market, the applications of major players and the market size, and deeply analyzes the current situation of the global NK Cell Therapy market and the development prospects and opportunities of NK Cell Therapy industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global NK Cell Therapy market in Chapter 13.
By Player:
NKT Therapeutics (USA)
Chipscreen Biosciences (China)
Sorrento Therapeutics Inc (USA)
Bristol-Myers Squibb (USA)
Altor BioScience Corporation (USA)
NantKwest Inc (USA)
Innate Pharma SA (France)
Affimed NV (Netherlands)
Takeda Pharmaceutical (Japan)
By Type:
Mogamulizumab
Lorvotuzumab Mertansine
Others
By End-User:
Cancer
Cardiovascular Diseases
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 NK Cell Therapy Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 NK Cell Therapy Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 NK Cell Therapy Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 NK Cell Therapy Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise NK Cell Therapy Market Analysis and Outlook to 2022
-
7.1 Global NK Cell Therapy Consumption (2017-2022)
-
7.2 United States NK Cell Therapy Consumption (2017-2022)
-
7.3 Europe NK Cell Therapy Consumption (2017-2022)
-
7.4 China NK Cell Therapy Consumption (2017-2022)
-
7.5 Japan NK Cell Therapy Consumption (2017-2022)
-
7.6 India NK Cell Therapy Consumption (2017-2022)
-
7.7 South Korea NK Cell Therapy Consumption (2017-2022)
8 Region and Country-wise NK Cell Therapy Market Analysis and Outlook to 2028
-
8.1 Global NK Cell Therapy Consumption Forecast (2022-2028)
-
8.2 United States NK Cell Therapy Consumption Forecast (2022-2028)
-
8.3 Europe NK Cell Therapy Consumption Forecast (2022-2028)
-
8.4 China NK Cell Therapy Consumption Forecast (2022-2028)
-
8.5 Japan NK Cell Therapy Consumption Forecast (2022-2028)
-
8.6 India NK Cell Therapy Consumption Forecast (2022-2028)
-
8.7 South Korea NK Cell Therapy Consumption Forecast (2022-2028)
9 Global NK Cell Therapy Market Outlook by Types and Applications to 2022
-
9.1 Global NK Cell Therapy Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Mogamulizumab Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Lorvotuzumab Mertansine Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global NK Cell Therapy Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global NK Cell Therapy Market Outlook by Types and Applications to 2028
-
10.1 Global NK Cell Therapy Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Mogamulizumab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Lorvotuzumab Mertansine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global NK Cell Therapy Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global NK Cell Therapy Import and Export Analysis (Top 5 Countries)
-
11.1 Global NK Cell Therapy Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global NK Cell Therapy Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 NK Cell Therapy Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global NK Cell Therapy Market Competitive Analysis
-
14.1 NKT Therapeutics (USA)
-
14.1.1 NKT Therapeutics (USA) Company Details
-
14.1.2 NKT Therapeutics (USA) NK Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 NKT Therapeutics (USA) NK Cell Therapy Product and Service
-
14.2 Chipscreen Biosciences (China)
-
14.2.1 Chipscreen Biosciences (China) Company Details
-
14.2.2 Chipscreen Biosciences (China) NK Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Chipscreen Biosciences (China) NK Cell Therapy Product and Service
-
14.3 Sorrento Therapeutics Inc (USA)
-
14.3.1 Sorrento Therapeutics Inc (USA) Company Details
-
14.3.2 Sorrento Therapeutics Inc (USA) NK Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Sorrento Therapeutics Inc (USA) NK Cell Therapy Product and Service
-
14.4 Bristol-Myers Squibb (USA)
-
14.4.1 Bristol-Myers Squibb (USA) Company Details
-
14.4.2 Bristol-Myers Squibb (USA) NK Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Bristol-Myers Squibb (USA) NK Cell Therapy Product and Service
-
14.5 Altor BioScience Corporation (USA)
-
14.5.1 Altor BioScience Corporation (USA) Company Details
-
14.5.2 Altor BioScience Corporation (USA) NK Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Altor BioScience Corporation (USA) NK Cell Therapy Product and Service
-
14.6 NantKwest Inc (USA)
-
14.6.1 NantKwest Inc (USA) Company Details
-
14.6.2 NantKwest Inc (USA) NK Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 NantKwest Inc (USA) NK Cell Therapy Product and Service
-
14.7 Innate Pharma SA (France)
-
14.7.1 Innate Pharma SA (France) Company Details
-
14.7.2 Innate Pharma SA (France) NK Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Innate Pharma SA (France) NK Cell Therapy Product and Service
-
14.8 Affimed NV (Netherlands)
-
14.8.1 Affimed NV (Netherlands) Company Details
-
14.8.2 Affimed NV (Netherlands) NK Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Affimed NV (Netherlands) NK Cell Therapy Product and Service
-
14.9 Takeda Pharmaceutical (Japan)
-
14.9.1 Takeda Pharmaceutical (Japan) Company Details
-
14.9.2 Takeda Pharmaceutical (Japan) NK Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Takeda Pharmaceutical (Japan) NK Cell Therapy Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of NK Cell Therapy
-
Figure NK Cell Therapy Picture
-
Table Global NK Cell Therapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global NK Cell Therapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global NK Cell Therapy Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global NK Cell Therapy Consumption by Country (2017-2022)
-
Figure United States NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Table Europe NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure China NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Japan NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure India NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure South Korea NK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global NK Cell Therapy Consumption Forecast by Country (2022-2028)
-
Figure United States NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure China NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure India NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea NK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mogamulizumab Consumption and Growth Rate (2017-2022)
-
Figure Global Lorvotuzumab Mertansine Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Mogamulizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lorvotuzumab Mertansine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global NK Cell Therapy Import by Region (Top 5 Countries) (2017-2028)
-
Table Global NK Cell Therapy Export by Region (Top 5 Countries) (2017-2028)
-
Table NKT Therapeutics (USA) (Foundation Year, Company Profile and etc.)
-
Table NKT Therapeutics (USA) NK Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table NKT Therapeutics (USA) NK Cell Therapy Product and Service
-
Table Chipscreen Biosciences (China) (Foundation Year, Company Profile and etc.)
-
Table Chipscreen Biosciences (China) NK Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Chipscreen Biosciences (China) NK Cell Therapy Product and Service
-
Table Sorrento Therapeutics Inc (USA) (Foundation Year, Company Profile and etc.)
-
Table Sorrento Therapeutics Inc (USA) NK Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sorrento Therapeutics Inc (USA) NK Cell Therapy Product and Service
-
Table Bristol-Myers Squibb (USA) (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb (USA) NK Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb (USA) NK Cell Therapy Product and Service
-
Table Altor BioScience Corporation (USA) (Foundation Year, Company Profile and etc.)
-
Table Altor BioScience Corporation (USA) NK Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Altor BioScience Corporation (USA) NK Cell Therapy Product and Service
-
Table NantKwest Inc (USA) (Foundation Year, Company Profile and etc.)
-
Table NantKwest Inc (USA) NK Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table NantKwest Inc (USA) NK Cell Therapy Product and Service
-
Table Innate Pharma SA (France) (Foundation Year, Company Profile and etc.)
-
Table Innate Pharma SA (France) NK Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Innate Pharma SA (France) NK Cell Therapy Product and Service
-
Table Affimed NV (Netherlands) (Foundation Year, Company Profile and etc.)
-
Table Affimed NV (Netherlands) NK Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Affimed NV (Netherlands) NK Cell Therapy Product and Service
-
Table Takeda Pharmaceutical (Japan) (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceutical (Japan) NK Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical (Japan) NK Cell Therapy Product and Service
-
